Table 3 Treatment adherence outcomes in patients with acromegaly receiving octreotide or lanreotide with 180-day washout period
Treatment | N | Variable | N | Mean | SE | Minimum | Maximum |
|---|---|---|---|---|---|---|---|
Octreotide | 545 | Treatment time (days) | 545 | 254.7 | 14.5 | 0 | 1563 |
Number of injections | 545 | 7.21 | 0.4 | 1 | 63 | ||
MPR (%) | 389 | 89 | 3 | 0.06 | 10 | ||
Lanreotide | 118 | Treatment time (days) | 118 | 351.8 | 34.2 | 0 | 1454 |
Number of injections | 118 | 10.2 | 0.9 | 1 | 49 | ||
MPR (%) | 99 | 87 | 4 | 0.13 | 3.8 |